BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37810490)

  • 21. Retracted: Role of Bioinformatics Analysis in Early Differential Diagnosis of Ovarian Cancer.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9865348. PubMed ID: 37502507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retracted: Abnormal GRHL2 Methylation Confers Malignant Progression to Acute Leukemia.
    And Biomechanics AB
    Appl Bionics Biomech; 2023; 2023():9837924. PubMed ID: 37621484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retracted: An Immune-Related Prognostic Risk Model in Colon Cancer by Bioinformatics Analysis.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9893576. PubMed ID: 37387801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retracted: Correlation Analysis of Ultrasound Elastography Score with Invasive Breast Cancer and Biological Prognostic Factors.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9871968. PubMed ID: 37520040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retracted: Correlation Analysis of DNA Methylation in the von Willebrand Factor Promoter Region and the Risk of Unexplained Recurrent Hemophilia: Systematic Review and Meta-Analysis.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9862856. PubMed ID: 37502509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene Signatures and Prognostic Values of m6A RNA Methylation Regulators in Ovarian Cancer.
    Han X; Liu J; Cheng G; Cui S
    Cancer Control; 2020; 27(1):1073274820960460. PubMed ID: 32951457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retracted: The Analysis of Potential Diagnostic and Therapeutic Targets for the Occurrence and Development of Gastric Cancer Based on Bioinformatics.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9802153. PubMed ID: 37885854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retracted: Analysis of the Relationship between the Expression Level of TTR and APOH and Prognosis in Patients with Colorectal Cancer Metastasis Based on Bioinformatics.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9791234. PubMed ID: 37810497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retracted: MiR-1270 Suppresses the Malignant Progression of Breast Cancer via Targeting MMD2.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9843621. PubMed ID: 37564800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retracted: Integrated Bioinformatics Analysis for Identification of the Hub Genes Linked with Prognosis of Ovarian Cancer Patients.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9826839. PubMed ID: 38094343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retracted: METTL3 Accelerates Breast Cancer Progression via Regulating EZH2 m
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9815081. PubMed ID: 37860497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive analysis of m6A RNA methylation modification patterns and the immune microenvironment in osteoarthritis.
    Liu Z; Liu H; Li D; Ma L; Lu T; Sun H; Zhang Y; Yang H
    Front Immunol; 2023; 14():1128459. PubMed ID: 37006311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. m6A RNA methylation regulators contribute to malignant development and have a clinical prognostic effect on cervical cancer.
    Ma X; Li Y; Wen J; Zhao Y
    Am J Transl Res; 2020; 12(12):8137-8146. PubMed ID: 33437387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retracted: Hub Gene Screening and Prognostic Modeling of Lung Cancer: An Integrated Bioinformatics Study.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9834087. PubMed ID: 37475946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of clinical prognostic features of esophageal cancer based on m6A regulators.
    Wang H; Zhang Y; Chen L; Liu Y; Xu C; Jiang D; Song Q; Wang H; Wang L; Lin Y; Chen Y; Chen J; Xu Y; Hou Y
    Front Immunol; 2022; 13():950365. PubMed ID: 36159855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retracted:
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9867274. PubMed ID: 38094437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Retracted] miR‑143‑5p suppresses breast cancer progression by targeting the HIF‑1α‑related GLUT1 pathway.
    Xu J; Li X; Zhang P; Luo J; Mou E; Liu S
    Oncol Lett; 2024 Jul; 28(1):311. PubMed ID: 38784604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Correlation between Ferroptosis and m6A Methylation in Patients with Acute Kidney Injury.
    Ni L; Bai R; Zhou Q; Yuan C; Zhou LT; Wu X
    Kidney Blood Press Res; 2022; 47(8):523-533. PubMed ID: 35569444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The m6A methylation regulator-based signature for predicting the prognosis of prostate cancer.
    Wang J; Lin H; Zhou M; Xiang Q; Deng Y; Luo L; Liu Y; Zhu Z; Zhao Z
    Future Oncol; 2020 Oct; 16(30):2421-2432. PubMed ID: 32687727
    [No Abstract]   [Full Text] [Related]  

  • 40. Retracted: lncRNA GHET1 Promotes the Progression of Triple-Negative Breast Cancer via Regulation of miR-377-3p/GRSF1 Signaling Axis.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9785034. PubMed ID: 37416294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.